News

Filter

Current filters:

Pharming

1 to 9 of 20 results

SOBI and Pharming extend and amend Ruconest agreement

SOBI and Pharming extend and amend Ruconest agreement

13-10-2014

Biotech companies Pharming Group and Swedish Orphan Biovitrum have amended and extended the Ruconest…

BiotechnologyHematologyMarkets & MarketingPharmingRuconestSobiSweden

Pharming acquires Transgenic Rabbit Models assets and accesses five new product leads

Pharming acquires Transgenic Rabbit Models assets and accesses five new product leads

19-08-2014

Dutch biotech company Pharming Group says that, through the acquisition of certain assets of Transgenic…

BiotechnologyMergers & AcquisitionsNetherlandsPharmingPharming Group NVTreatment of Pompe’s disease

Pharming and Salix gain US approval for Ruconest

Pharming and Salix gain US approval for Ruconest

17-07-2014

Netherlands-based Pharming Group and Salix Pharmaceuticals have received approval from the US Food and…

BiotechnologyPharmingRare diseasesRegulationRuconestSalix PharmaceuticalsUSA

Pharming income drops in 2013 but expects sales to grow this year

06-03-2014

Dutch biotech firm Pharming Group saw its shares rise 8.7% to 0.60 euros after publishing its preliminary…

BiotechnologyFinancialNetherlandsPharmingRuconest

MegaPharm receives marketing and reimbursement approval for Ruconest in Israel

15-01-2014

Privately-owned Israeli pharmaceutical company MegaPharm, partner of Dutch biotech company Pharming Group…

Cardio-vascularMegapharmPharmaceuticalPharmingRegulationRuconest

Pharming and SIPI collaboration includes Ruconest marketing in China

02-07-2013

Dutch biotech company Pharming Group (NYSE Euronext: PHARM) and Shanghai Institute of Pharmaceutical…

Asia-PacificBiotechnologyCardio-vascularLicensingPharmaceuticalPharmingResearchRuconestSinopharm Group

US FDA accepts Ruconest filing from Santarus and Pharming

18-06-2013

US drugmaker Santarus (Nasdaq: SNTS) and Netherlands-based Pharming Group (NYSE Euronext: PHARM) say…

BiotechnologyCardio-vascularNorth AmericaPharmingRare diseasesRegulationRuconestSantarus

Pharming and Santarus file BLA for Ruconest with US FDA

18-04-2013

Netherlands-based Pharming Group (NYSE Euronext: PHARM) and US licensee Santarus (Nasdaq: SNTS) have…

North AmericaPharmaceuticalPharmingRare diseasesRegulationRuconestSantarus

1 to 9 of 20 results

COMPANY SPOTLIGHT

Menarini

Back to top